This slide show has been prepared to be presented in the 4th edition of World Congress on Endocrinology, Diabetes and Metabolism, (EDM 2023 Congress)
Sep 07-08, 2023,
Rome, Italy
This document discusses preserving homeostasis in patients with COVID-19 by modulating the renin-angiotensin system (RAS). It describes how SARS-CoV-2 infection can dysregulate RAS, leading to overactivation of angiotensin II and oxidative stress. The use of angiotensin receptor blockers like losartan is proposed to counteract this and inhibit virus replication by distorting the binding of the virus to ACE2 receptors. Studies in cell cultures found losartan treatment before and after infection reduced viral replication. Maintaining RAS homeostasis is proposed as a promising therapeutic strategy for COVID-19 given the dysregulatory impacts of viral infections.
The current study investigated the immunomodulatory
potential of ethyl acetate soluble supernatant of
Lactobacillus casei (LC-EAS) in vitro. The effect of
LC-EAS on nitric oxide release was analyzed in RAW
264.7 cells, wherein, an inhibition in nitric oxide production
through suppression of inducible nitric oxide synthase
mRNA expression was observed. Evaluation of LC-EAS
on LPS-induced peripheral blood mononuclear cells
showed a down-regulation in TNF-a and IL-6 genes and an
upregulation of IL-10. An inhibition in the protein
expression of NF-kB, ERK1/2 and STAT3 phosphorylation
confirms the immunomodulatory potential of LC-EAS. The
effect of LC-EAS on in vitro intestinal epithelial cells was
investigated using HT-29 human colon adenocarcinoma
cancer cells. LC-EAS exhibited an inhibition of NF-jB and
ERK1/2 phosphorylation, whereas STAT3 phosphorylation
was unregulated. To evaluate the downstream target of
STAT3 upregulation, expression of the intestinal trefoil
factor TFF3 which is a NF-jB regulator and STAT3
downstream target was studied. LC-EAS was observed to
elevate TFF3 mRNA expression. Overall the study shows
that the anti-inflammatory potential of LC-EAS is through
inhibition of NF-kB in different cell types.
The document discusses DNA repair mechanisms in human lymphocytes. It describes how oxidized purines in DNA are repaired through the base excision repair pathway involving the OGG1 glycosylase. This repair requires activation by the transcription factor NF-YA, which upregulates OGG1 expression when DNA is at risk of oxidation. The repair of oxidized bases by OGG1 in human lymphocytes is slow but can be activated by phytohemagglutinin. Disruption of this global repair of oxidized purines may be due to downregulation of OGG1. A second document discusses how green tea acts as an antioxidant to protect against oxidative stress and influence DNA damage and repair through activation of the Nrf2 transcription factor and upreg
Abstract
Multicellular organisms constantly encounter potentially harmful microorganisms. Although insects lack an adaptive immune system, they do have powerful means of fighting infections. Cellular responses involve phagocytosis of bacteria and encapsulation of parasites. In addition, insects can mount a humoral response against pathogens. This is characterized by the secretion of antimicrobial peptides into the hemolymph. Recognition of foreign pathogens involves specific receptors for sensing infection. These include peptidoglycan recognition proteins (PGRPs) and β‐glucan recognition proteins (βGRPs). Engagement of these receptors starts signaling pathways that activate the genes that encode antimicrobial peptides. These pathways include the Toll, the Imd, and the JAK‐STAT.
Signalling pathways for activating genes for antimicrobial peptidesMogili Ramaiah
The document discusses the signaling pathways that activate the insect immune system. It describes three main pathways - the Toll pathway, IMD pathway, and JAK/STAT pathway. The Toll pathway involves recognition of pathogens by peptidoglycan recognition proteins which activate Spaetzle and the NF-κB transcription factor. The IMD pathway recognizes Gram-negative bacteria through PGRP-LC and activates the NF-κB factor. The JAK/STAT pathway involves binding of cytokines to the Dome receptor which phosphorylates STAT proteins to activate gene transcription. Together, these pathways precisely regulate the insect immune response through production of antimicrobial peptides and other effector mechanisms.
genes addiion\deeion\ediionthat lead to a therapeutic, prophylactic or diagnostic effect
Plasmid DNA
•Viral vectors
•Genetically engineered micro-organisms
•Human gene-editing technology
•Patient-derived cellular gene therapy products
Caspases are cysteine-dependent aspartate specific proteases that cleave target proteins after aspartic acid residues. They exist as inactive zymogens called procaspases in cells and initiate a proteolytic cascade when activated. This leads to cleavage of key proteins and characteristic apoptosis morphology. The Bcl-2 family of proteins regulate apoptosis at the mitochondrial membrane, with pro-apoptotic proteins like Bax activating apoptosis and anti-apoptotic proteins like Bcl-2 inhibiting apoptosis. Many cancers acquire mutations in genes encoding proteins that regulate apoptosis, allowing cancer cells to evade cell death signals and continue uncontrolled proliferation. Targeting apoptosis pathways is a promising strategy for cancer treatment.
This document summarizes research on the role of reactive oxygen species (ROS) in human fertility. It finds that ROS are produced naturally in the body but can also be generated by leukocytes, abnormal sperm, and other sources. While low levels play a role in fertilization, high levels of ROS can damage lipids, proteins, DNA and impair sperm motility and the ability of sperm to fuse with eggs. This leads to decreased sperm counts and quality, as well as DNA damage that may cause embryo death, miscarriage or birth defects. Antioxidants normally neutralize ROS, but when levels are too high it causes oxidative stress that contributes to infertility in both males and females.
This document discusses preserving homeostasis in patients with COVID-19 by modulating the renin-angiotensin system (RAS). It describes how SARS-CoV-2 infection can dysregulate RAS, leading to overactivation of angiotensin II and oxidative stress. The use of angiotensin receptor blockers like losartan is proposed to counteract this and inhibit virus replication by distorting the binding of the virus to ACE2 receptors. Studies in cell cultures found losartan treatment before and after infection reduced viral replication. Maintaining RAS homeostasis is proposed as a promising therapeutic strategy for COVID-19 given the dysregulatory impacts of viral infections.
The current study investigated the immunomodulatory
potential of ethyl acetate soluble supernatant of
Lactobacillus casei (LC-EAS) in vitro. The effect of
LC-EAS on nitric oxide release was analyzed in RAW
264.7 cells, wherein, an inhibition in nitric oxide production
through suppression of inducible nitric oxide synthase
mRNA expression was observed. Evaluation of LC-EAS
on LPS-induced peripheral blood mononuclear cells
showed a down-regulation in TNF-a and IL-6 genes and an
upregulation of IL-10. An inhibition in the protein
expression of NF-kB, ERK1/2 and STAT3 phosphorylation
confirms the immunomodulatory potential of LC-EAS. The
effect of LC-EAS on in vitro intestinal epithelial cells was
investigated using HT-29 human colon adenocarcinoma
cancer cells. LC-EAS exhibited an inhibition of NF-jB and
ERK1/2 phosphorylation, whereas STAT3 phosphorylation
was unregulated. To evaluate the downstream target of
STAT3 upregulation, expression of the intestinal trefoil
factor TFF3 which is a NF-jB regulator and STAT3
downstream target was studied. LC-EAS was observed to
elevate TFF3 mRNA expression. Overall the study shows
that the anti-inflammatory potential of LC-EAS is through
inhibition of NF-kB in different cell types.
The document discusses DNA repair mechanisms in human lymphocytes. It describes how oxidized purines in DNA are repaired through the base excision repair pathway involving the OGG1 glycosylase. This repair requires activation by the transcription factor NF-YA, which upregulates OGG1 expression when DNA is at risk of oxidation. The repair of oxidized bases by OGG1 in human lymphocytes is slow but can be activated by phytohemagglutinin. Disruption of this global repair of oxidized purines may be due to downregulation of OGG1. A second document discusses how green tea acts as an antioxidant to protect against oxidative stress and influence DNA damage and repair through activation of the Nrf2 transcription factor and upreg
Abstract
Multicellular organisms constantly encounter potentially harmful microorganisms. Although insects lack an adaptive immune system, they do have powerful means of fighting infections. Cellular responses involve phagocytosis of bacteria and encapsulation of parasites. In addition, insects can mount a humoral response against pathogens. This is characterized by the secretion of antimicrobial peptides into the hemolymph. Recognition of foreign pathogens involves specific receptors for sensing infection. These include peptidoglycan recognition proteins (PGRPs) and β‐glucan recognition proteins (βGRPs). Engagement of these receptors starts signaling pathways that activate the genes that encode antimicrobial peptides. These pathways include the Toll, the Imd, and the JAK‐STAT.
Signalling pathways for activating genes for antimicrobial peptidesMogili Ramaiah
The document discusses the signaling pathways that activate the insect immune system. It describes three main pathways - the Toll pathway, IMD pathway, and JAK/STAT pathway. The Toll pathway involves recognition of pathogens by peptidoglycan recognition proteins which activate Spaetzle and the NF-κB transcription factor. The IMD pathway recognizes Gram-negative bacteria through PGRP-LC and activates the NF-κB factor. The JAK/STAT pathway involves binding of cytokines to the Dome receptor which phosphorylates STAT proteins to activate gene transcription. Together, these pathways precisely regulate the insect immune response through production of antimicrobial peptides and other effector mechanisms.
genes addiion\deeion\ediionthat lead to a therapeutic, prophylactic or diagnostic effect
Plasmid DNA
•Viral vectors
•Genetically engineered micro-organisms
•Human gene-editing technology
•Patient-derived cellular gene therapy products
Caspases are cysteine-dependent aspartate specific proteases that cleave target proteins after aspartic acid residues. They exist as inactive zymogens called procaspases in cells and initiate a proteolytic cascade when activated. This leads to cleavage of key proteins and characteristic apoptosis morphology. The Bcl-2 family of proteins regulate apoptosis at the mitochondrial membrane, with pro-apoptotic proteins like Bax activating apoptosis and anti-apoptotic proteins like Bcl-2 inhibiting apoptosis. Many cancers acquire mutations in genes encoding proteins that regulate apoptosis, allowing cancer cells to evade cell death signals and continue uncontrolled proliferation. Targeting apoptosis pathways is a promising strategy for cancer treatment.
This document summarizes research on the role of reactive oxygen species (ROS) in human fertility. It finds that ROS are produced naturally in the body but can also be generated by leukocytes, abnormal sperm, and other sources. While low levels play a role in fertilization, high levels of ROS can damage lipids, proteins, DNA and impair sperm motility and the ability of sperm to fuse with eggs. This leads to decreased sperm counts and quality, as well as DNA damage that may cause embryo death, miscarriage or birth defects. Antioxidants normally neutralize ROS, but when levels are too high it causes oxidative stress that contributes to infertility in both males and females.
Prime-ome: "A molecular approach towards defense priming"Dhanya AJ
Prime-ome is the entire set of messenger RNA (mRNA) molécules or transcripts, proteins and metabolites produced or modified by an organism or system during the different stages of priming in plants and prime-omics is the study of prime-ome.
A normal cell can be transformed into a cancerous cell. Discuss the therapeut...DebbieAng2
Therapeutic strategies for targeting cellular transformation and preventing/treating cancer include inhibiting transforming growth factor-β (TGF-β) signaling, using antisense oligonucleotides, monoclonal antibodies, kinase inhibitors or aptamers that interfere with downstream SMAD proteins in the TGF-β pathway. Bacterial therapy is also being explored which uses bacteria's ability to preferentially target tumors and activate the immune system or deliver antitumor therapeutics specifically to cancer cells. However, these approaches face challenges regarding safety, delivery methods and translating findings between hosts.
Molecular mechanisms of action and potential biomarkers of growth inhibition ...Enrique Moreno Gonzalez
Molecular targeted therapy has emerged as a promising treatment of Hepatocellular carcinoma (HCC). One potential target is the Src family Kinase (SFK). C-Src, a non-receptor tyrosine kinase is a critical link of multiple signal pathways that regulate proliferation, invasion, survival, metastasis, and angiogenesis. In this study, we evaluated the effects of a novel SFK inhibitor, dasatinib (BMS-354825), on SFK/FAK/p130CAS, PI3K/PTEN/Akt/mTOR, Ras/Raf/MAPK and Stats pathways in 9 HCC cell lines.
Vitamin C inhibits FAS-induced apoptosis in monocytes and U937 cells by reducing caspase activity and ROS levels. The study found that loading cells with high intracellular concentrations of vitamin C through DHA administration blocked FAS-mediated apoptosis. Vitamin C's primary effect was inhibiting caspase-8 activation, with a separate impact on preserving mitochondrial membrane integrity and reducing ROS. This illuminates vitamin C's role in modulating redox signaling in FAS-induced apoptosis of immune cells.
Protein targets in Mycobacterium tuberculosis and their inhibitors for therap...Souparnika Sreelatha
Advancement in the area of anti-tubercular drug development has been full-fledged, yet, a very less number of
drug molecules have reached phase II clinical trials, and therefore “End-TB” is still a global challenge. Inhibitors
to specific metabolic pathways of Mycobacterium tuberculosis (Mtb) gain importance in strategizing antituberculosis
drug discovery. The lead compounds that target DNA replication, protein synthesis, cell wall
biosynthesis, bacterial virulence and energy metabolism are emerging as potential chemotherapeutic options
against Mtb growth and survival within the host. In recent times, the in silico approaches have become most
promising tools in the identification of suitable inhibitors for specific protein targets of Mtb. An update in the
fundamental understanding of these inhibitors and the mechanism of interaction may bring hope to future
perspectives in novel drug development and delivery approaches. This review provides a collective impression of
the small molecules with potential antimycobacterial activities and their target pathways in Mtb such as cell wall
biosynthesis, DNA replication, transcription and translation, efflux pumps, antivirulence pathways and general
metabolism. The mechanism of interaction of specific inhibitor with their respective protein targets has been
discussed. The comprehensive knowledge of such an impactful area of research would essentially reflect in the
discovery of novel drug molecules and effective delivery approaches. This narrative review encompasses the
knowledge of emerging targets and promising chemical inhibitors that could potentially translate in to the anti-
TB-drug discovery.
This document provides information about an anti-ADAMTS2 monoclonal antibody that targets the ADAMTS2 protein. It summarizes that ADAMTS2 is a protein coding gene involved in the degradation of the extracellular matrix. Mutations in ADAMTS2 cause Ehlers-Danlos syndrome type VIIC, a connective tissue disorder characterized by fragile tissues and joint hypermobility. The monoclonal antibody in this document targets a region of the ADAMTS2 protein and can be used for applications like western blotting and ELISA.
Human mesenchymal stem cells (MSC) are important tools for several cell-based therapies. However, their
use in such therapies requires in vitro expansion during which MSCs quickly reach replicative senescence. Recent studies
on the other hand, have implicated telomerase in the cellular response to oxidative damage, suggesting that telomerase has
a telomere-length independent function that promotes survival. Here, we studied the DNA damage accumulation
and repair during in vitro expansion as well as after acute external oxidative exposure of control MSCs and MSCs that
overexpress the catalytic subunit of telomerase (hTERT MSCs). We showed that hTERT MSCs at high passages
have a significant lower percentage of DNA lesions as compared to control cells of the same passages. Additionally, less damage was accumulated due to external oxidative insult in the nuclei of hTERT overexpressing cells as compared to the
control cells. Moreover, we demonstrated that oxidative stress leads to diverse nucleus malformations, such as multillobular
nuclei or donut-shaped nuclei, in the control cells whereas hTERT MSCs showed significant resistance to the formation
of such defects. On the basis of these results, we propose that hTERT enhancement confers resistance to genomic damage due to the amelioration of the cell’s basic antioxidant machinery.
This study found that acute myeloid leukemia (AML) cells driven by the fusion oncogenes AML1-ETO and PML-RARα have increased DNA damage and are more sensitive to PARP inhibitors compared to AML cells driven by MLL-AF9. Sensitivity to PARP inhibitors was correlated with lower expression of DNA damage response genes. The study also found that modulating the activity of the oncogene HOXA9, which is highly expressed in MLL-AF9 AML, could render those cells sensitive to PARP inhibitors by reducing DNA repair capacity. Combining PARP inhibitors with agents that target HOXA9 may be a promising new therapeutic strategy for AML.
Scientists at EpiVax are widely considered to be thought-leaders in the fields of immunogenicity screening, deimmunization, immunomodulation and T cell vaccine design. They have produced a prolific volume of quality publications in top journals and continue to do so annually.
The document discusses how the SUMO E3-ligase PIAS1 couples reactive oxygen species (ROS)-dependent JNK activation to oxidative cell death in human endometrial stromal cells (HESCs). It finds that ROS-dependent JNK activation converges on the SUMO pathway via PIAS1. Knockdown of PIAS1 prevents ROS-dependent hypersumoylation but enhances JNK signaling in HESCs. PIAS1 determines the level of JNK activity, couples ROS signaling to the SUMO pathway, and promotes oxidative cell death. PIAS1 knockdown attenuates ROS-dependent caspase activation and apoptosis.
Non-biological gene carriers designed for overcoming the major extra- and int...Nanomedicine Journal (NMJ)
Abstract
Gene therapy as a modern therapeutic approach has not yet advanced to a globally-approved therapeutic approach. Lack of adequate reliable gene delivery system seems to be one of the major reasons from the pharmaceutical biotechnology point of view. Main obstacles delaying successful application of human gene therapy are presented in this review. The unique advantages of non-biological gene carriers as compared to their biological counterparts make them ideal alternatives for overcoming extra- and intracellular barriers in a more safely manner. We, therefore, highlight the significant contributions in non-biological gene delivery and favorable characteristics of different design attitudes with focus on in vivo approaches. Bypassing the rapid extracellular enzymatic degradation of genetic materials is covered in extracellular segment of this review with emphasis on PEGylated and targeted formulations. The successful approaches to pave the rest of the way from cellular uptake to intracellular transfer and gene expression of unpacked DNA are also discussed. From these approaches, we emphasize more on optimization of cationic-based polymers and dendrimers, developing newly designed membrane-effective components, and adjusting the hydrophilic-hydrophobic balance of the synthesized vectors
1) Anti-angiogenic therapy targets tumor angiogenesis and has become an established treatment for metastatic colorectal cancer (mCRC).
2) Bevacizumab, a monoclonal antibody targeting VEGF, has shown efficacy in multiple phase III trials in combination with chemotherapy as first-line and maintenance therapy for mCRC.
3) Additional anti-angiogenic agents approved for mCRC include aflibercept, ramucirumab, and regorafinib, which have demonstrated benefits in later lines of therapy.
The Role of Nrf2 in the Attenuation of Cardiovascular DiseaseLifeVantage
This document discusses the role of the transcription factor Nrf2 in attenuating cardiovascular disease through regulating antioxidant defenses. It begins by explaining how oxidative stress contributes to cardiovascular diseases and how early trials of antioxidant supplements were disappointing. It then describes how Nrf2 is the master regulator of cellular antioxidant defenses, regulating over 200 genes. Nrf2 is normally bound by Keap1 in the cytoplasm and targeted for degradation, but oxidative stress or phytochemicals can activate Nrf2 by modifying Keap1 or through kinase signaling. Activated Nrf2 upregulates antioxidant enzymes and other genes to maintain redox homeostasis and protect against disease. Exercise and certain phytochemicals are highlighted as potential ways to activate Nrf2 and attenu
Inhibition of glutathione by buthionine sulfoximine enhanced the anti-cancer ...Ashujit
Multiple myeloma (MM) is an incurable blood cancer. Melphalan is an alkylating agent given prior to stem cell transplantation to MM patients. Increased glutathione confers resistance to melphalan. This study investigate the effect of inhibition of glutathione by BSO in preclinical models of MM. Pretreatment with BSO enhanced the anti-cancer effect of melphalan in cell lines and animal models. BSO and melphalan combination was well tolerated by animals and enhanced the survival as compared to controls, BSO and melphalan alone. BSO enhanced depth and duration of responses induced by melphalan. In the combination group, majority of treated animals achieved complete response (CR) and more than 20% had maintained CR. Also, the survival of animals was doubled after combination treatment as compared to BSO or melphalan alone. Mechanistic investigation demonstrated that BSO enhanced melphalan induced DNA damage, caspase cleavage and apoptosis. The combination also achieved multi-logs of cells kills in nine human multiple myeloma cell lines and primary MM cells isolated from blood and bone marrows. Interestingly, the effect of BSO and melphalan combination was abolished when cells were treated with N-acetyl cysteine and sodium thiosulfate but not with vitamin C and vitamin E. This observation suggests that effect of BSO is primarily driven by its ability to deplete glutathione and therefore preventing melphalan detoxification. Together, this study provides framework for testing the combination in a Phase I trial.
MAP4K1's role in regulating acute myeloid leukemia prognosis and drug resistance against HHT was explored through in vitro and in vivo experiments. Cell viability, apoptosis, and cell cycle assays were used to analyze protein levels of MAP4K1, JNK, and C-JUN in AML cell lines. The study found that molecular biology tools can help determine various types of DNA and cellular damage, and their diagnostic use in diseases is an important area of medical research.
The document discusses SKBR3 and MCF-7 breast cancer cell lines, which are HER2 positive and negative, respectively. An experiment was conducted to test the cytotoxic effect of an scFv(Herceptin)-PE-stxa recombinant immunotoxin on these cell lines using an MTT assay. The immunotoxin demonstrated cytotoxicity in a HER2-dependent manner, selectively killing the HER2-positive SKBR3 cells but having little effect on the HER2-negative MCF-7 cells. This shows the potential for targeted immunotherapy against HER2-positive breast cancers.
monoclonal antibodies and engineered antibodiesMunawar Ali
This document provides an overview of monoclonal antibodies and engineered antibodies. It discusses the advantages and disadvantages of monoclonal versus polyclonal antibodies. Production methods like hybridoma technology and fermentation are described. Problems associated with monoclonal antibody therapy like HAMA response are covered. Applications in diagnosis, therapy and analytical uses are mentioned. Finally, the document discusses engineering antibodies by modifying regions to reduce immunogenicity and enhance functions.
The document discusses arterial blood gas (ABG) analysis and its potential use as an indicator of physical endurance following cardiac surgery. It provides background on cardiac rehabilitation programs and exercises that can improve cardiopulmonary function and quality of life after surgery. ABG analysis measures parameters related to ventilation, acid-base balance, and oxygenation. Precise interpretation of ABG results can guide medical management and identify acid-base disorders that may require intervention.
COVID-19 poses a serious global health threat in the 21st century. There are currently no approved vaccines or antiviral treatments for COVID-19. The virus enters cells by binding to the ACE2 receptor and causes severe lung damage. High levels of proinflammatory cytokines are associated with worse outcomes. Blocking the renin-angiotensin system may help attenuate acute respiratory distress syndrome. Computational studies indicate certain molecules may reduce the affinity of SARS-CoV-2 for the ACE2 receptor.
Prime-ome: "A molecular approach towards defense priming"Dhanya AJ
Prime-ome is the entire set of messenger RNA (mRNA) molécules or transcripts, proteins and metabolites produced or modified by an organism or system during the different stages of priming in plants and prime-omics is the study of prime-ome.
A normal cell can be transformed into a cancerous cell. Discuss the therapeut...DebbieAng2
Therapeutic strategies for targeting cellular transformation and preventing/treating cancer include inhibiting transforming growth factor-β (TGF-β) signaling, using antisense oligonucleotides, monoclonal antibodies, kinase inhibitors or aptamers that interfere with downstream SMAD proteins in the TGF-β pathway. Bacterial therapy is also being explored which uses bacteria's ability to preferentially target tumors and activate the immune system or deliver antitumor therapeutics specifically to cancer cells. However, these approaches face challenges regarding safety, delivery methods and translating findings between hosts.
Molecular mechanisms of action and potential biomarkers of growth inhibition ...Enrique Moreno Gonzalez
Molecular targeted therapy has emerged as a promising treatment of Hepatocellular carcinoma (HCC). One potential target is the Src family Kinase (SFK). C-Src, a non-receptor tyrosine kinase is a critical link of multiple signal pathways that regulate proliferation, invasion, survival, metastasis, and angiogenesis. In this study, we evaluated the effects of a novel SFK inhibitor, dasatinib (BMS-354825), on SFK/FAK/p130CAS, PI3K/PTEN/Akt/mTOR, Ras/Raf/MAPK and Stats pathways in 9 HCC cell lines.
Vitamin C inhibits FAS-induced apoptosis in monocytes and U937 cells by reducing caspase activity and ROS levels. The study found that loading cells with high intracellular concentrations of vitamin C through DHA administration blocked FAS-mediated apoptosis. Vitamin C's primary effect was inhibiting caspase-8 activation, with a separate impact on preserving mitochondrial membrane integrity and reducing ROS. This illuminates vitamin C's role in modulating redox signaling in FAS-induced apoptosis of immune cells.
Protein targets in Mycobacterium tuberculosis and their inhibitors for therap...Souparnika Sreelatha
Advancement in the area of anti-tubercular drug development has been full-fledged, yet, a very less number of
drug molecules have reached phase II clinical trials, and therefore “End-TB” is still a global challenge. Inhibitors
to specific metabolic pathways of Mycobacterium tuberculosis (Mtb) gain importance in strategizing antituberculosis
drug discovery. The lead compounds that target DNA replication, protein synthesis, cell wall
biosynthesis, bacterial virulence and energy metabolism are emerging as potential chemotherapeutic options
against Mtb growth and survival within the host. In recent times, the in silico approaches have become most
promising tools in the identification of suitable inhibitors for specific protein targets of Mtb. An update in the
fundamental understanding of these inhibitors and the mechanism of interaction may bring hope to future
perspectives in novel drug development and delivery approaches. This review provides a collective impression of
the small molecules with potential antimycobacterial activities and their target pathways in Mtb such as cell wall
biosynthesis, DNA replication, transcription and translation, efflux pumps, antivirulence pathways and general
metabolism. The mechanism of interaction of specific inhibitor with their respective protein targets has been
discussed. The comprehensive knowledge of such an impactful area of research would essentially reflect in the
discovery of novel drug molecules and effective delivery approaches. This narrative review encompasses the
knowledge of emerging targets and promising chemical inhibitors that could potentially translate in to the anti-
TB-drug discovery.
This document provides information about an anti-ADAMTS2 monoclonal antibody that targets the ADAMTS2 protein. It summarizes that ADAMTS2 is a protein coding gene involved in the degradation of the extracellular matrix. Mutations in ADAMTS2 cause Ehlers-Danlos syndrome type VIIC, a connective tissue disorder characterized by fragile tissues and joint hypermobility. The monoclonal antibody in this document targets a region of the ADAMTS2 protein and can be used for applications like western blotting and ELISA.
Human mesenchymal stem cells (MSC) are important tools for several cell-based therapies. However, their
use in such therapies requires in vitro expansion during which MSCs quickly reach replicative senescence. Recent studies
on the other hand, have implicated telomerase in the cellular response to oxidative damage, suggesting that telomerase has
a telomere-length independent function that promotes survival. Here, we studied the DNA damage accumulation
and repair during in vitro expansion as well as after acute external oxidative exposure of control MSCs and MSCs that
overexpress the catalytic subunit of telomerase (hTERT MSCs). We showed that hTERT MSCs at high passages
have a significant lower percentage of DNA lesions as compared to control cells of the same passages. Additionally, less damage was accumulated due to external oxidative insult in the nuclei of hTERT overexpressing cells as compared to the
control cells. Moreover, we demonstrated that oxidative stress leads to diverse nucleus malformations, such as multillobular
nuclei or donut-shaped nuclei, in the control cells whereas hTERT MSCs showed significant resistance to the formation
of such defects. On the basis of these results, we propose that hTERT enhancement confers resistance to genomic damage due to the amelioration of the cell’s basic antioxidant machinery.
This study found that acute myeloid leukemia (AML) cells driven by the fusion oncogenes AML1-ETO and PML-RARα have increased DNA damage and are more sensitive to PARP inhibitors compared to AML cells driven by MLL-AF9. Sensitivity to PARP inhibitors was correlated with lower expression of DNA damage response genes. The study also found that modulating the activity of the oncogene HOXA9, which is highly expressed in MLL-AF9 AML, could render those cells sensitive to PARP inhibitors by reducing DNA repair capacity. Combining PARP inhibitors with agents that target HOXA9 may be a promising new therapeutic strategy for AML.
Scientists at EpiVax are widely considered to be thought-leaders in the fields of immunogenicity screening, deimmunization, immunomodulation and T cell vaccine design. They have produced a prolific volume of quality publications in top journals and continue to do so annually.
The document discusses how the SUMO E3-ligase PIAS1 couples reactive oxygen species (ROS)-dependent JNK activation to oxidative cell death in human endometrial stromal cells (HESCs). It finds that ROS-dependent JNK activation converges on the SUMO pathway via PIAS1. Knockdown of PIAS1 prevents ROS-dependent hypersumoylation but enhances JNK signaling in HESCs. PIAS1 determines the level of JNK activity, couples ROS signaling to the SUMO pathway, and promotes oxidative cell death. PIAS1 knockdown attenuates ROS-dependent caspase activation and apoptosis.
Non-biological gene carriers designed for overcoming the major extra- and int...Nanomedicine Journal (NMJ)
Abstract
Gene therapy as a modern therapeutic approach has not yet advanced to a globally-approved therapeutic approach. Lack of adequate reliable gene delivery system seems to be one of the major reasons from the pharmaceutical biotechnology point of view. Main obstacles delaying successful application of human gene therapy are presented in this review. The unique advantages of non-biological gene carriers as compared to their biological counterparts make them ideal alternatives for overcoming extra- and intracellular barriers in a more safely manner. We, therefore, highlight the significant contributions in non-biological gene delivery and favorable characteristics of different design attitudes with focus on in vivo approaches. Bypassing the rapid extracellular enzymatic degradation of genetic materials is covered in extracellular segment of this review with emphasis on PEGylated and targeted formulations. The successful approaches to pave the rest of the way from cellular uptake to intracellular transfer and gene expression of unpacked DNA are also discussed. From these approaches, we emphasize more on optimization of cationic-based polymers and dendrimers, developing newly designed membrane-effective components, and adjusting the hydrophilic-hydrophobic balance of the synthesized vectors
1) Anti-angiogenic therapy targets tumor angiogenesis and has become an established treatment for metastatic colorectal cancer (mCRC).
2) Bevacizumab, a monoclonal antibody targeting VEGF, has shown efficacy in multiple phase III trials in combination with chemotherapy as first-line and maintenance therapy for mCRC.
3) Additional anti-angiogenic agents approved for mCRC include aflibercept, ramucirumab, and regorafinib, which have demonstrated benefits in later lines of therapy.
The Role of Nrf2 in the Attenuation of Cardiovascular DiseaseLifeVantage
This document discusses the role of the transcription factor Nrf2 in attenuating cardiovascular disease through regulating antioxidant defenses. It begins by explaining how oxidative stress contributes to cardiovascular diseases and how early trials of antioxidant supplements were disappointing. It then describes how Nrf2 is the master regulator of cellular antioxidant defenses, regulating over 200 genes. Nrf2 is normally bound by Keap1 in the cytoplasm and targeted for degradation, but oxidative stress or phytochemicals can activate Nrf2 by modifying Keap1 or through kinase signaling. Activated Nrf2 upregulates antioxidant enzymes and other genes to maintain redox homeostasis and protect against disease. Exercise and certain phytochemicals are highlighted as potential ways to activate Nrf2 and attenu
Inhibition of glutathione by buthionine sulfoximine enhanced the anti-cancer ...Ashujit
Multiple myeloma (MM) is an incurable blood cancer. Melphalan is an alkylating agent given prior to stem cell transplantation to MM patients. Increased glutathione confers resistance to melphalan. This study investigate the effect of inhibition of glutathione by BSO in preclinical models of MM. Pretreatment with BSO enhanced the anti-cancer effect of melphalan in cell lines and animal models. BSO and melphalan combination was well tolerated by animals and enhanced the survival as compared to controls, BSO and melphalan alone. BSO enhanced depth and duration of responses induced by melphalan. In the combination group, majority of treated animals achieved complete response (CR) and more than 20% had maintained CR. Also, the survival of animals was doubled after combination treatment as compared to BSO or melphalan alone. Mechanistic investigation demonstrated that BSO enhanced melphalan induced DNA damage, caspase cleavage and apoptosis. The combination also achieved multi-logs of cells kills in nine human multiple myeloma cell lines and primary MM cells isolated from blood and bone marrows. Interestingly, the effect of BSO and melphalan combination was abolished when cells were treated with N-acetyl cysteine and sodium thiosulfate but not with vitamin C and vitamin E. This observation suggests that effect of BSO is primarily driven by its ability to deplete glutathione and therefore preventing melphalan detoxification. Together, this study provides framework for testing the combination in a Phase I trial.
MAP4K1's role in regulating acute myeloid leukemia prognosis and drug resistance against HHT was explored through in vitro and in vivo experiments. Cell viability, apoptosis, and cell cycle assays were used to analyze protein levels of MAP4K1, JNK, and C-JUN in AML cell lines. The study found that molecular biology tools can help determine various types of DNA and cellular damage, and their diagnostic use in diseases is an important area of medical research.
The document discusses SKBR3 and MCF-7 breast cancer cell lines, which are HER2 positive and negative, respectively. An experiment was conducted to test the cytotoxic effect of an scFv(Herceptin)-PE-stxa recombinant immunotoxin on these cell lines using an MTT assay. The immunotoxin demonstrated cytotoxicity in a HER2-dependent manner, selectively killing the HER2-positive SKBR3 cells but having little effect on the HER2-negative MCF-7 cells. This shows the potential for targeted immunotherapy against HER2-positive breast cancers.
monoclonal antibodies and engineered antibodiesMunawar Ali
This document provides an overview of monoclonal antibodies and engineered antibodies. It discusses the advantages and disadvantages of monoclonal versus polyclonal antibodies. Production methods like hybridoma technology and fermentation are described. Problems associated with monoclonal antibody therapy like HAMA response are covered. Applications in diagnosis, therapy and analytical uses are mentioned. Finally, the document discusses engineering antibodies by modifying regions to reduce immunogenicity and enhance functions.
The document discusses arterial blood gas (ABG) analysis and its potential use as an indicator of physical endurance following cardiac surgery. It provides background on cardiac rehabilitation programs and exercises that can improve cardiopulmonary function and quality of life after surgery. ABG analysis measures parameters related to ventilation, acid-base balance, and oxygenation. Precise interpretation of ABG results can guide medical management and identify acid-base disorders that may require intervention.
COVID-19 poses a serious global health threat in the 21st century. There are currently no approved vaccines or antiviral treatments for COVID-19. The virus enters cells by binding to the ACE2 receptor and causes severe lung damage. High levels of proinflammatory cytokines are associated with worse outcomes. Blocking the renin-angiotensin system may help attenuate acute respiratory distress syndrome. Computational studies indicate certain molecules may reduce the affinity of SARS-CoV-2 for the ACE2 receptor.
This review article was presented in the 7th International joint cardiovascular congress held on Feb 28-29, 2019, in Convention Center, Shahid Rejaee Heart Hospital, Tehran, Iran
The metabolic syndrome is a constellation of conditions that increases the risk of atherosclerotic cardiovascular disease and type 2 diabetes. It is characterized by central obesity, high blood pressure, high blood sugar, high triglycerides, and low HDL cholesterol. The metabolic syndrome is caused by excess caloric intake and sedentary lifestyle and predisposes patients to insulin resistance. It affects 10-40% of adults worldwide and presents a major health challenge.
Cardiac rehabilitation (CR) is a multidisciplinary program that helps patients restore health and reduce future heart risks after a cardiac event. CR includes exercise training, risk factor modification, and psychosocial support. The goals are to influence the underlying heart disease, optimize physical and mental health, and help patients resume normal activities. CR is delivered in phases from the hospital through long-term maintenance. Exercise training in CR increases cardiovascular fitness and muscle adaptations, lowering heart rate and blood pressure during activity. Arterial blood gases are analyzed to assess respiratory function and acid-base status, and guide safe exercise progression in CR.
Erythropoietin (EPO) is a hormone that regulates red blood cell production but also has neuroprotective properties. It is produced in the kidney and liver in response to hypoxia and its receptor is present in the nervous system. EPO protects neurons from apoptosis, oxidative stress, and excitotoxicity through multiple signaling pathways. It also protects the blood-brain barrier integrity and supports angiogenesis, neurogenesis, and synaptogenesis. The document presents several case studies where EPO was administered to patients with brain injuries such as hemorrhage and ischemia and seemed to improve outcomes.
The document discusses the role of cytokines in mental status and neurological conditions. It states that cytokines are small signaling proteins released during inflammation that can influence cognition, mood, and behavior. Elevated cytokine levels are associated with depression, anxiety, and stress disorders. Cytokines like IL-1β, TNF-α, and IL-6 are involved in modulating memory and synaptic plasticity in the hippocampus. They have also been linked to delirium, cognitive impairment, and neurodegenerative disorders. While acute inflammation is normal, chronic or dysregulated cytokine activity can negatively impact mental functioning through effects on the brain and neurotransmitter systems.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...Donc Test
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd Edition by DeMarco, Walsh, Verified Chapters 1 - 25, Complete Newest Version TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd Edition by DeMarco, Walsh, Verified Chapters 1 - 25, Complete Newest Version TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd Edition by DeMarco, Walsh, Verified Chapters 1 - 25, Complete Newest Version Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Pdf Chapters Download Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Pdf Download Stuvia Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Study Guide Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Ebook Download Stuvia Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Questions and Answers Quizlet Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Studocu Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Quizlet Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Stuvia Community and Public Health Nursing: Evidence for Practice 3rd Edition Pdf Chapters Download Community and Public Health Nursing: Evidence for Practice 3rd Edition Pdf Download Course Hero Community and Public Health Nursing: Evidence for Practice 3rd Edition Answers Quizlet Community and Public Health Nursing: Evidence for Practice 3rd Edition Ebook Download Course hero Community and Public Health Nursing: Evidence for Practice 3rd Edition Questions and Answers Community and Public Health Nursing: Evidence for Practice 3rd Edition Studocu Community and Public Health Nursing: Evidence for Practice 3rd Edition Quizlet Community and Public Health Nursing: Evidence for Practice 3rd Edition Stuvia Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Pdf Chapters Download Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Pdf Download Stuvia Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Study Guide Questions and Answers Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Ebook Download Stuvia Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Questions Quizlet Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Studocu Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Quizlet Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Stuvia
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
1. ADAM17:
a sheddase involved at the crossroad of metabolism and immunity
by: Reza Nejat, M. D., FCCM; Anti-Doping, Nutrition, Metabolism Consultant
2. ADAM17:
a sheddase involved at the crossroad of
metabolism and immunity
Reza Nejat, M. D., FCCM,
Anesthesiology and Critical Care Dept., Laleh Hospital,
Anti-Doping, Nutrition and Metabolism Consultant, World Powerlifting Ltd.,
Eurasia Division (Asia, Iran), Melbourne, Australia,
Former Assistant Professor, SBMU,
3. ADAM17:
a sheddase involved at the crossroad of
metabolism and immunity
Metabolism:
the whole sum of life-sustaining chemical
reactions:
occurring in cells and across whole organisms
endows the organism with the required energy
for:
fulfilling vital processes
synthesizing new organic material.
https://www.britannica.com/science/
metabolism
https://www.ncbi.nlm.nih.gov/books/
NBK546690/
by: Reza Nejat, M. D., FCCM; Anti-Doping, Nutrition, Metabolism Consultant
4. ADAM17:
a sheddase involved at the crossroad of
metabolism and immunity Immunometabolism:
There are shared factors which both
affect metabolism and regulate
immune responses:
TNF-α, TGF-β, IL-1, IL-6, IL-8, IFNγ,
Matarese, G.; La Cava, A.
Trends in immunology 2004, 25 (4),
193.
by: Reza Nejat, M. D., FCCM; Anti-Doping, Nutrition, Metabolism Consultant
5. ADAM17:
a sheddase involved at the crossroad of
metabolism and immunity
T cell development:
Requires activation PI3K-Akt-mTOR
pathway:
PI3K:
• dominates aerobic glycolysis
Akt:
• a major anabolism stimulus
mTOR:
♣ regulates glutaminolysis,
♣ glycolysis,
♣ mitochondrial biogenesis,
♣ protein synthesis
Zhang, M; et al.
Frontiers in Immunology 2022, 13,
946119
by: Reza Nejat, M. D., FCCM; Anti-Doping, Nutrition, Metabolism Consultant
6. ADAM17:
a sheddase involved at the crossroad of
metabolism and immunity
Activation of Quiescent Leukocytes:
needs their energy expenditure to increase
increase by a factor of 1.30-1.50 (30-50
(30-50 percent)
Straub, R.; et al.
Journal of internal medicine 2010,
267 (6), 543.
by: Reza Nejat, M. D., FCCM; Anti-Doping, Nutrition, Metabolism Consultant
7. ADAM17:
a sheddase involved at the crossroad of
metabolism and immunity Resting Metabolic Rate:
Should escalate up to 8-14% for
for activation of only mild forms of
forms of immune reaction.
Muehlenbein, M. P.; et al.
American Journal of Human Biology:
The Official Journal of the Human
Biology Association 2010, 22 (4), 546.
by: Reza Nejat, M. D., FCCM; Anti-Doping, Nutrition, Metabolism Consultant
8. ADAM17:
a sheddase involved at the crossroad of
metabolism and immunity Metabolic reprogramming:
changes in cell metabolism
required for activation of immune
cells
M1 Mφ (killer):
• glycolytic metabolism
M2 Mφ (healer):
• TCA metabolism
Russell, D. G.; et al.
Nature Reviews Immunology 2019,
19 (5), 291.
Ley, K.
The Journal of Immunology 2017,
199 (7), 2191
by: Reza Nejat, M. D., FCCM; Anti-Doping, Nutrition, Metabolism Consultant
9. ADAM17:
a sheddase involved at the crossroad of
metabolism and immunity
Transmembrane proteolysis:
a crucial contributor to in signal
transduction.
cleaves many of transmembrane
proteins to be released as soluble
molecules,
the soluble molecules initiate
cellular or intercellular signal
transduction
Wang, K.; et al.
Frontiers in Immunology 2022, 13,
1059376.
by: Reza Nejat, M. D., FCCM; Anti-Doping, Nutrition, Metabolism Consultant
10. ADAM17:
a sheddase involved at the crossroad of
metabolism and immunity Mφ Metabolic Reprogramming:
Leads to activation of HIF-ADAM17
ADAM17 pathway
Lian, G.; et al.
EBioMedicine 2019, 49, 291
by: Reza Nejat, M. D., FCCM; Anti-Doping, Nutrition, Metabolism Consultant
11. ADAM17:
a sheddase involved at the crossroad of
metabolism and immunity
Nejat, R.; Torshizi, M. F.; Najafi, D.
J. S Protein, ACE2 and Host Cell
Proteases in SARS-CoV-2 Cell Entry
and Infectivity; Is Soluble ACE2 a
Two Blade Sword? A Narrative
Review. Vaccines 2023, 11 (2), 204.
by: Reza Nejat, M. D., FCCM; Anti-Doping, Nutrition, Metabolism Consultant
12. ADAM17:
a sheddase involved at the crossroad of
metabolism and immunity
Nejat, R.; Torshizi, M. F.; Najafi, D.
J. S Protein, ACE2 and Host Cell
Proteases in SARS-CoV-2 Cell Entry
and Infectivity; Is Soluble ACE2 a
Two Blade Sword? A Narrative
Review. Vaccines 2023, 11 (2), 204.
by: Reza Nejat, M. D., FCCM; Anti-Doping, Nutrition, Metabolism Consultant
13. ADAM17:
a sheddase involved at the crossroad of
metabolism and immunity
ADAM17:
A member of ADAM family
Type I transmembrane protein
Exists in two forms:
Precursor
Activated
Critical for cleaving ectodomain of
many membrane proteins:
Cytokines (TNF-α, IL-6, IL-8, Il-10),
10),
ACE2,
Growth factors (EGF),
Receptors (TNF-R, IL-6R, EGF-R),
Pref-1
Adhesion molecules,
Wang, K.; et al.
Frontiers in Immunology 2022, 13,
1059376.
De Queiroz, T. M.; et al.
Frontiers in Pharmacology 2020, 11,
1154.
Matthews, J.; et al. Bioscience Reports
2021, 41 (5), BSR20210029
by: Reza Nejat, M. D., FCCM; Anti-Doping, Nutrition, Metabolism Consultant
14. ADAM17:
a sheddase involved at the crossroad of
metabolism and immunity
ADAM17:
cleaving ectodomain of:
♣Cytokines (TNF-α, IL-6, IL-8, Il-10),
♣ACE2,
♣Growth factors (EGF),
♣Receptors (TNF-R, IL-6R, EGF-R),
♣Pref-1
♣Adhesion molecules,
Wang, K.; et al.
Frontiers in Immunology 2022, 13,
1059376.
De Queiroz, T. M.; et al.
Frontiers in Pharmacology 2020, 11,
1154.
Matthews, J.; et al. Bioscience Reports
2021, 41 (5), BSR20210029
by: Reza Nejat, M. D., FCCM; Anti-Doping, Nutrition, Metabolism Consultant
15. ADAM17:
a sheddase involved at the crossroad of
metabolism and immunity Knockdown of ADAM17:
Downregulates EGFR-PI3K-Akt-
mTOR (survival) pathway
Leads to extremely lean
phenotype
Ameliorates cardiac dysfunction
in diabetic CMP
Zhang, Q.; et al.
Biochemical and biophysical research
communications 2018, 503 (4), 2333
Matthews, J; et al.
Bioscience Reports 2021, 41 (5),
BSR20210029.
Xue, F.; et al.
Signal Transduction and Targeted
Therapy 2022, 7 (1), 259.
by: Reza Nejat, M. D., FCCM; Anti-Doping, Nutrition, Metabolism Consultant
16. ADAM17:
a sheddase involved at the crossroad of
metabolism and immunity ADAM17 shedding of EGFR
ligands:
Promotes tumor associated
macrophage M2 polarization
through EGFR-PI3K-Akt-mTOR
(survival) pathway
Wang, K.; et al. Frontiers in
Immunology 2022, 13, 1059376
by: Reza Nejat, M. D., FCCM; Anti-Doping, Nutrition, Metabolism Consultant
17. ADAM17:
a sheddase involved at the crossroad of
metabolism and immunity ADAM17:
Mediates shedding of pro-
inflammatory TNF-α
Induces shedding of Insulin
Receptor ectodomain:
♣Promotes insulin resistance
♣Impairs insulin-mediated vasodilation
vasodilation
Ghiarone, T.; et al.
American Journal of Physiology-
Heart and Circulatory Physiology
2022, 323 (4), H688
by: Reza Nejat, M. D., FCCM; Anti-Doping, Nutrition, Metabolism Consultant
18. ADAM17:
a sheddase involved at the crossroad of
metabolism and immunity
ADAM17:
• Cleaves SEMA4B
SEMA4B inhibits adipocytes:
♣Differentiation
♣Thermogenesis
♣Lipid catabolism
SEMA4B seems to mediate
recruitment of Tregs and
immunosuppressive cells
Amin, A.; et al. Molecular
Metabolism 2023, 73, 101731.
Jiang, J.; et al. BMC cancer 2022, 22
(1), 632.
by: Reza Nejat, M. D., FCCM; Anti-Doping, Nutrition, Metabolism Consultant
19. ADAM17:
a sheddase involved at the crossroad of
metabolism and immunity ADAM17:
Upregulates in adipose tissue
endothelial cells through aging:
remote coronary microvascular
dysfunction
In white adipose tissue leads to:
expression of IL-6, MCP-1, SOCS3
low-grade inflammatory status
Dou, H.; et al.
Arteriosclerosis, thrombosis, and
vascular biology 2017, 37 (6), 1180
Menghini, R.; et al.
Atherosclerosis 2013, 228 (1), 12.
Serino, M.; et al.
Diabetes 2007, 56 (10), 2541
by: Reza Nejat, M. D., FCCM; Anti-Doping, Nutrition, Metabolism Consultant
20. ADAM17:
a sheddase involved at the crossroad of
metabolism and immunity ADAM17:
• Modulates both metabolism and
immunity,
• Its downregulation and overexpression are
both hazardous,
• A special molecule as a promising target in:
• immunometabolic derangements,
• autoimmunity and cancer treatment
Conclusion
by: Reza Nejat, M. D., FCCM; Anti-Doping, Nutrition, Metabolism Consultant
21. ADAM17:
a sheddase involved at the
crossroad of metabolism
and immunity
by: Reza Nejat, M. D., FCCM; Anti-Doping, Nutrition, Metabolism Consultant